高级检索
中华结核和呼吸杂志
期刊首页
过刊列表
高级检索
稿件发表
• 综述 •
ENGLISH ABSTRACT
造血干细胞移植患者巨细胞病毒肺炎的诊治进展
李秋钰
路明
姚婉贞
作者及单位信息
·
DOI： 10.3760/cma.j.issn.1001-0939.2019.02.012
Progress in diagnosis and treatment of cytomegalovirus pneumonia in patients after hematopoietic cell transplantation
Li Qiuyu
Lu Ming
Yao Wanzhen
Authors Info & Affiliations
Li Qiuyu
Lu Ming
Yao Wanzhen
·
DOI： 10.3760/cma.j.issn.1001-0939.2019.02.012
1352
4345
0
2
9
1
PDF下载
APP内阅读
摘要

造血干细胞移植患者由于免疫功能低下，易发生潜伏巨细胞病毒（cytomegalovirus，CMV）的再激活，其中CMV肺炎是患者移植失败及死亡的重要原因。本文综述了CMV肺炎的危险因素、发病机制、临床表现、胸部影像学特点，以及当前最新的的诊断方法和治疗策略，以期临床医生给予本病更多的关注。

引用本文

李秋钰,路明,姚婉贞. 造血干细胞移植患者巨细胞病毒肺炎的诊治进展[J]. 中华结核和呼吸杂志,2019,42(2)：134-137.

DOI:10.3760/cma.j.issn.1001-0939.2019.02.012

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价

版权归中华医学会所有。

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

巨细胞病毒（cytomegalovirus，CMV）感染是免疫功能受损患者常见的机会性感染。血液系统恶性肿瘤患者，尤其是异基因造血干细胞移植后，更容易出现重症CMV感染。而CMV肺炎，即使给予了积极的抗病毒治疗，病死率依然高达30%~50% [ 1 , 2 ]。现将近年来CMV肺炎的诊治进展综述如下。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Konoplev S , Champlin RE , Giralt S ,et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients[J]. Bone Marrow Transplant, 2001,27(8):877-881. DOI: 10.1038/sj.bmt.1702877 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Travi G , Pergam SA . Cytomegalovirus pneumonia in hematopoietic stem cell recipients[J]. J Intensive Care Med, 2014,29(4):200-2012. DOI: 10.1177/0885 066613476454 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Manicklal S , Emery VC , Lazzarotto T ,et al. The "silent" global burden of congenital cytomegalovirus[J]. Clin Microbiol Rev, 2013,26(1):86-102. DOI: 10.1128/CMR.00062-12 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Styczynski J . Who is the Patient at Risk of CMV Recurrence: a Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation[J]. Infect Dis Ther, 2018,7(1):1-16. DOI: 10.1007/s40121-017-0180-z .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Dziedzic M , Sadowska-Krawczenko I , Styczynski J . Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification[J]. Anticancer Res, 2017,37(12):6551-6556. DOI: 10.21873/anticanres.12111 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
邹秉含，张钦，许亚茹，等. 异基因造血干细胞移植后巨细胞病毒感染的危险因素分析[J]. 中国实验血液学杂志， 2016，24(2):551-555．DOI: 10.7534/j.issn.1009-2137.2016.02.046 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
赵晓甦，刘代红，许兰平，等. 异基因造血干细胞移植后巨细胞病毒肺炎临床特点分析[J]. 北京大学学报（医学版）， 2009，41(5):548-553．DOI: 10.3969/j.issn.1671-167X.2009.05.009 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Erard V , Guthrie KA , Seo S ,et al. Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices[J]. Clin Infect Dis, 2015,61(1):31-39. DOI: 10.1093/cid/civ215 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Gasparetto EL , Ono SE , Escuissato D ,et al. Cytomegalovirus pneumonia after bone marrow transplantation: high resolution CT findings[J]. Br J Radiol, 2004,77(921):724-727. DOI: 10.1259/bjr/70800575 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Kunihiro Y , Tanaka N , Matsumoto T ,et al. The usefulness of a diagnostic method combining high-resolution CT findings and serum markers for cytomegalovirus pneumonia and pneumocystis pneumonia in non-AIDS patients[J]. Acta Radiol, 2015,56(7):806-813. DOI: 10.1177/0284185114539320 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Shteinberg M , Shaked-Mishan P , Kinarti A ,et al. Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients[J]. Lung, 2014,192(6):875-879. DOI: 10.1007/s00408-014-9644-z .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Ljungman P , Boeckh M , Hirsch HH ,et al. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials[J]. Clin Infect Dis, 2017,64(1):87-91. DOI: 10.1093/cid/ciw668 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Kotton CN , Kumar D , Caliendo AM ,et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation[J]. Transplantation, 2018,102(6):900-931. DOI: 10.1097/TP.0 000000000002191 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Dioverti MV , Lahr BD , Germer JJ ,et al. Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease[J]. Open Forum Infect Dis, 2017,4(3):ofx143. DOI: 10.1093/ofid/ofx143 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Boeckh M , Stevens-Ayers T , Travi G ,et al. Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia[J]. J Infect Dis, 2017,215(10):1514-1522. DOI: 10.1093/infdis/jix048 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Fryer JF , Heath AB , Minor PD ,et al. Collaborative Study Group. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology[J]. Biologicals, 2016,44(4):242-251. DOI: 10.1016/j.biologicals.2016.04.005 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Beam E , Germer JJ , Lahr B ,et al. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia[J]. Clin Transplant, 2018,32(1):e13149. DOI: 10.1111/ctr.13149 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Crawford SW , Hackman RC , Clark JG . Open lung biopsy diagnosis of diffuse pulmonary infiltrates after marrow transplantation[J]. Chest, 1988,94(5):949-953. DOI: 10.1378/chest.94.5.949 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Choi SM , Lee DG , Lim J ,et al. Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients[J]. J Korean Med Sci, 2009,24(4):571-578. DOI: 10.3346/jkms.2009.24.4.571 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Ljungman P , de la Camara R , Cordonnier C ,et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT[J]. Bone Marrow Transplant, 2008,42(4):227-240. DOI: 10.1038/bmt.2008.162 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Ljungman P , Hakki M , Boeckh M . Cytomegalovirus in hematopoietic stem cell transplant recipients[J]. Infect Dis Clin North Am, 2010,24(2):319-337. DOI: 10.1016/j.idc.2010.01.008 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Locatelli F , Bertaina A , Bertaina V ,et al. Cytomegalovirus in hematopoietic stem cell transplant recipients-management of infection[J]. Expert Rev Hematol, 2016,9(11):1093-1105. DOI: 10.1080/17474086.2016.1242406 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Avery RK , Arav-Boger R , Marr KA ,et al. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection[J]. Transplantation, 2016,100(10):e74-80. DOI: 10.1097/TP.0000 000000001418 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Ljungman P , Deliliers GL , Platzbecker U ,et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation[J]. Blood, 2001,97(2):388-392. DOI: 10.1182/blood.V97.2.388 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Frange P , Leruez-Ville M . Maribavir, brincidofovir and letermovir: efficacy and safety of new antiviral drugs for treating cytomegalovirus infections[J]. Med Mal Infect, 2018,48(8):495-502. DOI: 10.1016/j.medmal.2018.03.006 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Alexander BT , Hladnik LM , Augustin KM ,et al. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients[J]. Pharmacotherapy, 2010,30(6):554-561. DOI: 10.1592/phco.30.6.554 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
费继光，陈立中，王长希，等. 糖皮质激素在治疗肾移植术后巨细胞病毒性重症肺炎中的作用[J]. 中华器官移植杂志， 2005，26(12):748-750．DOI: 10.3760/cma.j.issn.0254-1785.2005.12.013 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
赵建平，周戈会，张惠兰，等. 糖皮质激素治疗肾移植术后巨细胞病毒肺炎[J]. 中华器官移植杂志， 2007，28(11):678-680．DOI: 10.3760/cma.j.issn.0254-1785.2007.11.011 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Riddell SR , Watanabe KS , Goodrich JM ,et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones[J]. Science, 1992,257(5067):238-241. DOI: 10.1126/science.1352912 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
邹秉含，张斌，陈虎. 细胞毒性T淋巴细胞治疗人巨细胞病毒感染在造血干细胞移植中的应用[J]. 中国实验血液学杂志， 2016，24(2):616-621．DOI: 10.7534/j.issn.1009-2137.2016.02.058 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Baugh KA , Tzannou I , Leen AM . Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients[J]. Curr Opin Infect Dis, 2018,31(4):292-300. DOI: 10.1097/QCO.0000000000000456 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
路明，Email： mocdef.3ab61459791gnimul
B
所有作者均声明不存在利益冲突
C
美捷登青年科学家研究基金资助 (Grant No. MJR20180030)
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
最新推荐
更多
造血干细胞移植患者的妇产科管理专家共识
中华医学会妇产科学分会绝经学组 等
中华妇产科杂志 2022,57(06)
中国多发性骨髓瘤自体造血干细胞移植指南（2021年版）
中华医学会血液学分会浆细胞疾病学组 等
中华血液学杂志 2021,42(05)
中国异基因造血干细胞移植治疗血液系统疾病专家共识（Ⅲ）——急性移植物抗宿主病（2020年版）
中华医学会血液学分会干细胞应用学组
中华血液学杂志 2020,41(07)
造血干细胞移植患者巨细胞病毒肺炎的诊治进展
郑秀 等
国际呼吸杂志 2018,38(17)
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大